Dolby Laboratories (NYSE:DLB – Get Free Report) CEO Kevin J. Yeaman sold 25,000 shares of the business’s stock in a transaction dated Tuesday, June 24th. The stock was sold at an average price of $74.02, for a total transaction of $1,850,500.00. Following the sale, the chief executive officer now directly owns 114,725 shares in the company, valued at $8,491,944.50. The trade was a 17.89% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Dolby Laboratories Stock Performance
Shares of Dolby Laboratories stock opened at $74.87 on Friday. The stock has a market capitalization of $7.19 billion, a PE ratio of 28.25 and a beta of 0.93. Dolby Laboratories has a 52-week low of $66.35 and a 52-week high of $89.66. The company has a 50-day simple moving average of $74.98 and a two-hundred day simple moving average of $78.11.
Dolby Laboratories (NYSE:DLB – Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The electronics maker reported $1.34 EPS for the quarter, beating analysts’ consensus estimates of $1.29 by $0.05. The firm had revenue of $369.56 million for the quarter, compared to analysts’ expectations of $375.44 million. Dolby Laboratories had a net margin of 19.44% and a return on equity of 11.48%. The business’s revenue for the quarter was up 1.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.27 earnings per share. As a group, equities research analysts forecast that Dolby Laboratories will post 2.94 EPS for the current fiscal year.
Dolby Laboratories Dividend Announcement
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of the business. Alpine Bank Wealth Management purchased a new stake in shares of Dolby Laboratories during the first quarter valued at $25,000. Cheviot Value Management LLC bought a new position in Dolby Laboratories during the 1st quarter valued at about $27,000. MAI Capital Management boosted its holdings in shares of Dolby Laboratories by 87.1% during the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock valued at $28,000 after acquiring an additional 162 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Dolby Laboratories during the 1st quarter valued at about $29,000. Finally, Global X Japan Co. Ltd. bought a new stake in shares of Dolby Laboratories in the first quarter worth approximately $51,000. Hedge funds and other institutional investors own 58.56% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts have recently issued reports on the stock. Barrington Research reiterated an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a report on Friday, May 2nd. Wall Street Zen upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Friday, May 30th. Rosenblatt Securities reissued a “buy” rating and issued a $95.00 target price on shares of Dolby Laboratories in a report on Friday, June 13th. Finally, Tigress Financial assumed coverage on Dolby Laboratories in a research note on Thursday, May 15th. They issued a “buy” rating and a $112.00 target price on the stock.
Get Our Latest Analysis on Dolby Laboratories
Dolby Laboratories Company Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
See Also
- Five stocks we like better than Dolby Laboratories
- The Role Economic Reports Play in a Successful Investment Strategy
- Astera Labs: AI Infrastructure Play With Significant Growth Ahead
- Upcoming IPO Stock Lockup Period, Explained
- Is IBM’s AI Transformation Powering a Sustained Rally?
- What is a Microcap Stock? Everything You Need to Know
- NVIDIA’s Stock Price Hits New Highs: This Is What’s Next
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.